Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study

2016 ◽  
Vol 3 (5) ◽  
pp. e228-e236 ◽  
Author(s):  
Gary Raskob ◽  
Walter Ageno ◽  
Alexander T Cohen ◽  
Marjolein P A Brekelmans ◽  
Michael A Grosso ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Post Hoc Analysis ◽  
Extended Duration ◽  
Post Hoc

Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial

2017 ◽  
Vol 45 (1) ◽  
pp. 1-8 ◽  
Author(s):  
Megan K. Yee ◽  
Tarek Nafee ◽  
Yazan Daaboul ◽  
Serge Korjian ◽  
Fahad AlKhalfan ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Post Hoc Analysis ◽  
History Of ◽  
Post Hoc

Risk scores for occult cancer in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study

2018 ◽  
Vol 164 ◽  
pp. S224
Author(s):  
N. Kraaijpoel ◽  
N. van Es ◽  
G.E. Raskob ◽  
H.R. Büller ◽  
M. Carrier ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Risk Scores ◽  
Post Hoc Analysis ◽  
Occult Cancer ◽  
Post Hoc

Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial

2020 ◽  
Vol 195 ◽  
pp. 209-214
Author(s):  
Sabine Eichinger ◽  
Min Lin ◽  
Minggao Shi ◽  
Michael A. Grosso ◽  
Paul A. Kyrle
Keyword(s):  
Venous Thromboembolism ◽  
Post Hoc Analysis ◽  
Recurrent Venous Thromboembolism ◽  
Post Hoc
Sign in / Sign up

Export Citation Format

Share Document